Nantahala Capital Management, LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Nantahala Capital Management, LLC disclosed 132 US equity positions worth $1.7bn in its Q2 2026 13F filing. The largest position was TBBK at 4.7% of the reported book, followed by BVS and HGV. Against the Q1 2026 filing, it opened 3 new positions, added to 15 and reduced 21 among the top 50 holdings.
What did Nantahala Capital Management, LLC own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | TBBK BANCORP INC DEL | Financial Services | 4.7% | $77.7m | 1,239,887 | -10% | reduced |
| 2 | BVS BIOVENTUS INC | Healthcare | 3.4% | $56.6m | 6,000,279 | -2% | reduced |
| 3 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 3.3% | $54.1m | 1,033,170 | -32% | reduced |
| 4 | SVRA SAVARA INC | Healthcare | 2.6% | $43.0m | 6,976,810 | -5% | reduced |
| 5 | ETON ETON PHARMACEUTICALS INC | 2.6% | $42.6m | 1,175,951 | 0% | held | |
| 6 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 2.4% | $39.3m | 2,268,751 | -20% | reduced |
| 7 | EOLS EVOLUS INC | Healthcare | 2.3% | $38.9m | 5,602,021 | -12% | reduced |
| 8 | AVTX AVALO THERAPEUTICS INC | Healthcare | 2.1% | $34.4m | 1,862,250 | 51% | added |
| 9 | LB PHARMACEUTICALS INC | 2.1% | $34.2m | 1,052,894 | 0% | held | |
| 10 | AVR ANTERIS TECHNOLOGIES GLOBAL | 2.0% | $33.3m | 3,383,335 | -39% | reduced | |
| 11 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 1.9% | $31.7m | 5,136,490 | 2% | added |
| 12 | PTON PELOTON INTERACTIVE INC | Consumer Cyclical | 1.8% | $30.2m | 5,108,995 | -57% | reduced |
| 13 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 1.7% | $28.8m | 335,830 | -60% | reduced |
| 14 | XTNT XTANT MED HLDGS INC | 1.7% | $28.8m | 68,394,000 | 0% | held | |
| 15 | JACK JACK IN THE BOX INC | Consumer Cyclical | 1.7% | $27.3m | 1,728,659 | 12% | added |
| 16 | GOGO GOGO INC | Communication Services | 1.6% | $27.0m | 8,697,731 | -2% | reduced |
| 17 | IMAX IMAX CORP | Communication Services | 1.6% | $26.2m | 658,009 | 28% | added |
| 18 | ZVRA ZEVRA THERAPEUTICS INC | 1.6% | $25.8m | 1,797,476 | -29% | reduced | |
| 19 | TITN TITAN MACHY INC | Industrials | 1.4% | $23.9m | 1,133,088 | -10% | reduced |
| 20 | RMR RMR GROUP INC | 1.4% | $23.6m | 1,147,902 | 0% | held | |
| 21 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 1.4% | $22.8m | 5,505,128 | 2% | added |
| 22 | FOXF FOX FACTORY HLDG CORP | Consumer Cyclical | 1.3% | $22.2m | 1,310,695 | -12% | reduced |
| 23 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.3% | $22.1m | 820,481 | -8% | reduced |
| 24 | RDNW RIDENOW GROUP INC | 1.3% | $21.8m | 3,272,845 | 0% | held | |
| 25 | UNIQURE NV | 1.3% | $21.0m | 455,660 | 92% | added | |
| 26 | AURA AURA BIOSCIENCES INC | 1.3% | $21.0m | 2,951,030 | 39% | added | |
| 27 | AGOMAB THERAPEUTICS NV | 1.2% | $20.4m | 1,568,188 | 31% | added | |
| 28 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.2% | $20.0m | 5,475,040 | 80% | added |
| 29 | BENITEC BIOPHARMA INC | 1.2% | $19.9m | 1,488,371 | 3% | added | |
| 30 | ADMA ADMA BIOLOGICS INC | Healthcare | 1.2% | $19.8m | 2,359,993 | – | new |
| 31 | CWH CAMPING WORLD HLDGS INC | Consumer Cyclical | 1.2% | $19.5m | 2,551,055 | -22% | reduced |
| 32 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.1% | $19.0m | 1,901,160 | -4% | reduced |
| 33 | MDXG MIMEDX GROUP INC | Healthcare | 1.1% | $18.4m | 4,767,552 | 40% | added |
| 34 | ABVX ABIVAX SA | Healthcare | 1.1% | $17.8m | 133,759 | -3% | reduced |
| 35 | USNA USANA HEALTH SCIENCES INC | Consumer Defensive | 1.0% | $17.3m | 810,074 | 0% | held |
| 36 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 1.0% | $15.8m | 651,993 | 0% | held |
| 37 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.9% | $15.7m | 500,659 | -60% | reduced |
| 38 | GERN GERON CORP | Healthcare | 0.9% | $15.6m | 12,225,000 | 9% | added |
| 39 | VOR VOR BIOPHARMA INC | Healthcare | 0.9% | $15.6m | 845,000 | – | new |
| 40 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.9% | $15.1m | 1,410,419 | 4% | added |
| 41 | SLN SILENCE THERAPEUTICS PLC | 0.9% | $14.8m | 1,346,731 | -37% | reduced | |
| 42 | APYX APYX MEDICAL CORPORATION | Healthcare | 0.9% | $14.7m | 3,270,248 | -5% | reduced |
| 43 | JCAP JEFFERSON CAPITAL INC | 0.9% | $14.6m | 750,000 | 0% | held | |
| 44 | HLF HERBALIFE LTD | Consumer Defensive | 0.9% | $14.6m | 1,109,154 | -18% | reduced |
| 45 | PLNT PLANET FITNESS MASTER ISSUER | Consumer Cyclical | 0.9% | $14.6m | 279,000 | – | new |
| 46 | VSTM VERASTEM INC | Healthcare | 0.8% | $13.7m | 3,584,820 | 0% | held |
| 47 | DSGR DISTRIBUTION SOLUTIONS GRP I | 0.8% | $13.5m | 494,581 | 0% | held | |
| 48 | RYAM RAYONIER ADVANCED MATLS INC | Basic Materials | 0.8% | $13.3m | 1,697,726 | 6% | added |
| 49 | HELIX ACQUISITION CORP III | 0.8% | $13.3m | 1,250,000 | 0% | held | |
| 50 | ADCT ADC THERAPEUTICS SA | Healthcare | 0.8% | $13.2m | 12,326,184 | 120% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.